Gelonghui, May 7 | China Resources Shuanghe (600062.SH) announced that China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. (“Shuanghe Limin”), a wholly-owned subsidiary of the company, has received lidocaine hydrochloride injection (“this drug”) and “Drug Registration Certificate” (certificate number: 2024S00640) issued by the State Drug Administration.
Lidocaine hydrochloride injection is a local anesthetic and antiarrhythmic drug. It is mainly used for infiltration anesthesia, epidural anesthesia, surface anesthesia (including mucosal anesthesia during thoracoscopy or abdominal surgery) and nerve conduction block. It can also be used for premature ventricular stroke and ventricular tachycardia after acute myocardial infarction. It can also be used for ventricular arrhythmia caused by digitalis poisoning, cardiac surgery, and cardiac catheters.